Paul McCreadie joined Arboretum Ventures in 2006 and is responsible for sourcing and leading new investments in promising healthcare companies. He led Arboretum’s investment into Delphinus Medical Technologies and Wellfount Pharmacy and currently serves on the Board of Directors of each company. Paul has also been a board observer at VasoNova (acquired by Teleflex) and NeoGuide. He is the former Chief Operating Officer for CerviLenz, a portfolio company based in Ohio, where he led the re-design of the company’s first commercial product from concept to launch. Prior to joining Arboretum in 2006, Paul worked at Ford Motor Company for eight years, holding management positions within new product development, manufacturing, and business strategy. He was a member of the Wolverine Venture Fund (WVF) while an MBA student at Michigan's Ross School of Business. Paul was the fund’s liaison with IntraLase, one of the WVF's most successful investments to date, which was acquired by American Medical Optics in 2007.
Paul earned a BS and MS in Mechanical Engineering from the University of Michigan and an MBA from the Ross School of Business at the University of Michigan.